by Sharen Singh | Apr 9, 2021 | Alzheimer's Disease, I. Issues, II. Roles, IV. Others, Medical Officers
The CRISPR-Cas9 genome-editing system is a part of the adaptive immune system in archaea and bacteria to defend against invasive nucleic acids from phages and plasmids. The guide RNA (sgRNA) of the system recognizes its target sequence in the genome, and the Cas9...
by Marina Norfolk | Apr 9, 2021 | Anterior Cruciate Ligament Injury, Athletic, I. Issues, II. Roles, III. Solutions, Medical Officers, Physical Therapy / Medicine and Rehabilitation
Anterior cruciate ligament (ACL) injury is commonplace amongst athletes and individuals alike, yet despite its frequency, this injury devastatingly increases morbidity and greatly impacts one’s day-to-day schedule (1). ACL injuries comprise up to 50% of ligamentous...
by Sharen Singh | Mar 2, 2021 | Athletic, II. Roles, IV. Others, Medical Officers, Physical Therapy / Medicine and Rehabilitation
Total Knee Arthroplasty (TKA) and Total Joint Replacement (TJR) procedures are customarily used to surgically reconstruct or replace a joint. This procedure is frequently performed as a resolution for functional debilitation in the knee and knee pain management....
by Sophie Gilbert | Feb 21, 2021 | Biostabilizer, Low Back Pain, Medical Officers, Physical Therapy / Medicine and Rehabilitation
In the past three decades, time spent at work sitting has almost doubled from an average of 3.4 hours to 6.3 hours daily (1). This increasingly sedentary lifestyle has brought with it increased incidences of musculoskeletal discomfort. Additionally, the COVID-19...
by Marina Norfolk | Feb 20, 2021 | I. Issues, III. Solutions, Low Back Pain, Medical Officers
Lockdown measures that have been established to manage the ever-evolving COVID-19 pandemic have induced numerous changes across communities worldwide. In areas most affected by these societal changes, sleep quality has been noticeably impacted as a result of decreased...
by Smriti Haria | Feb 19, 2021 | Alzheimer's Disease, Medical Officers, Prescribers
As of 2014, 1.6% of the American population, 5 million people, were afflicted by Alzheimer’s Disease (AD) and other related dementias. This number is only expected to grow with a prediction that by 2060, AD and other dementias will affect 3.3% of Americans [1]. Like...
Recent Comments